Literature DB >> 936029

Primary neoplasms of the duodenum.

S K Shukla, E G Elias.   

Abstract

The records of 12 patients with primary malignant neoplasms of the duodenum, excluding ampullary lesions, have been studied. There were eight adenocarcinomas and four leiomyosarcomas. The second portion of the duodenum was the most common site for these neoplasms. Common symptoms were epigastric pain; obstructive symptoms, such as nausea and vomiting; obstructive jaundice, and hematemesis. Hematemesis is the most common symptom in leiomyosarcoma of the duodenum. The mean duration of symptoms was six months for leiomyosarcoma and 3.2 months for adenocarcinoma. In five patients, excision of the tumor was carried out more frequently for those in the distal portion of the duodenum. More radical procedures, such as pancreaticoduodenectomy, are the treatment of choice in neoplasms of the second portion of the duodenum. A bypass procedure is done for palliation of intestinal obstruction. Three patients with leiomyosarcomas that were resected had a mean survival time of 51 months. On the other hand, patients with adenocarcinomas that were resected had a mean survival time of nine months, while patients with unresectable tumors had a mean survival time of 2.3 months.

Entities:  

Mesh:

Year:  1976        PMID: 936029

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  9 in total

Review 1.  Treatment for superficial non-ampullary duodenal epithelial tumors.

Authors:  Naomi Kakushima; Hideyuki Kanemoto; Masaki Tanaka; Kohei Takizawa; Hiroyuki Ono
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  Leiomyosarcoma of the duodenum.

Authors:  M Kanematsu; T Imaeda; G Iinuma; S Mori; Y Yamawaki; H Doi; H Takao; K Shimokawa
Journal:  Gastrointest Radiol       Date:  1991

3.  Cold snare polypectomy for superficial non-ampullary duodenal epithelial tumor: a prospective clinical trial (pilot study).

Authors:  Kohei Takizawa; Naomi Kakushima; Masaki Tanaka; Noboru Kawata; Masao Yoshida; Yohei Yabuuchi; Yoshihiro Kishida; Kenichiro Imai; Sayo Ito; Hirotoshi Ishiwatari; Kinichi Hotta; Hiroyuki Matsubayashi; Keita Mori; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2021-12-02       Impact factor: 3.453

4.  Clinicopathological features and management strategy for superficial nonampullary duodenal tumors: a multi-center retrospective study.

Authors:  Eun Young Kim; Dong Jin Kim; Han Hong Lee; Jun Hyun Lee; Jeong Goo Kim; Kyo Young Song; Jin Jo Kim; Hyung Min Chin; Wook Kim
Journal:  Ann Surg Treat Res       Date:  2022-05-03       Impact factor: 1.766

5.  Dual primary adenocarcinoma of the duodenum and jejunum in a patient with previous colonic cancers.

Authors:  A C Swift; G T Smith; D L Douglas
Journal:  Postgrad Med J       Date:  1980-12       Impact factor: 2.401

6.  Primary carcinoma of the duodenum.

Authors:  A Alwmark; A Andersson; A Lasson
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

7.  Pancreas-sparing distal duodenectomy for infrapapillary neoplasms.

Authors:  D R C Spalding; A M Isla; J N Thompson; R C N Williamson
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

8.  The Impact of KRAS Mutation in Patients With Sporadic Nonampullary Duodenal Epithelial Tumors.

Authors:  Hideaki Kinugasa; Hiromitsu Kanzaki; Takehiro Tanaka; Shumpei Yamamoto; Yasushi Yamasaki; Kazuhiro Nouso; Kouichi Ichimura; Masahiro Nakagawa; Toshiharu Mitsuhashi; Hiroyuki Okada
Journal:  Clin Transl Gastroenterol       Date:  2021-11-18       Impact factor: 4.488

9.  Sporadic non-ampullary duodenal adenoma with low-grade dysplasia: Natural history and clinical management.

Authors:  Yohei Ikenoyama; Shoichi Yoshimizu; Ken Namikawa; Yoshitaka Tokai; Yusuke Horiuchi; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Junko Fujisaki
Journal:  Endosc Int Open       Date:  2022-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.